The Research Evangelist

Meet Dr. Yasir Elamin | From The Halls of ASCO 2026

Dave Bjork

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 10:36

I sat down with Dr. Yasir Elamin to get his thoughts on his presentation at ASCO regarding patient reported outcomes and health-related quality of life with Taletrectinib in advanced ROS1 non-small cell lung cancer (NSCLC)  from the TRUST-II Study.

Send us Fan Mail

researchevangelist.com